Table of Content

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights


2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology


3. Executive Summary
3.1. Global Lyophilized Injectable Drugs Market Size (US$ Mn) and Distribution, by Region, 2018 and 2026
3.2. Global Lyophilized Injectable Drugs Market: Market Snapshot


4. Market Overview
4.1. Global Lyophilized Injectable Drugs Market: Type of Packaging Overview
4.2. Global Lyophilized Injectable Drugs Market: Key Industry Developments
4.3. Market Dynamics
4.4. Drivers and Restraints Snapshot Analysis
4.5. Drivers
4.6. Restraints
4.7. Opportunities
4.8. Global Lyophilized Injectable Drugs Market Revenue Projections (US$ Mn), 2016–2026


5. Key Insights
5.1. Key Merger and Acquisitions
5.2. Regulatory Scenario, by Country/Region


6. Global Lyophilized Injectable Drugs Market Analysis, by Type of Packaging
6.1. Introduction
6.2. Global Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging
6.2.1. Single-use Vials
6.2.2. Point-of-Care Reconstitution
6.2.3. Specialty Packaging
6.2.4. Others
6.3. Global Lyophilized Injectable Drugs Market Analysis, by Type of Packaging
6.4. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Type of Packaging


7. Global Lyophilized Injectable Drugs Market Analysis, by Type of Delivery
7.1. Introduction
7.2. Global Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
7.2.1. Prefilled Diluent Syringes
7.2.2. Proprietary Reconstitution Devices
7.2.3. Single-step Devices
7.2.4. Multi-step Devices
7.3. Global Lyophilized Injectable Drugs Market Analysis, by Type of Delivery
7.4. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Type of Delivery


8. Global Lyophilized Injectable Drugs Market Analysis, by Indication
8.1. Introduction
8.2. Global Lyophilized Injectable Drugs Market Size and Forecast, by Indication
8.2.1. Autoimmune Diseases
8.2.2. Infectious Diseases
8.2.3. Metabolic Conditions
8.2.4. Others
8.3. Global Lyophilized Injectable Drugs Market Analysis, by Indication
8.4. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Indication


9. Global Lyophilized Injectable Drugs Market Analysis, by End-user
9.1. Introduction
9.2. Global Lyophilized Injectable Drugs Market Size and Forecast, by End-user
9.2.1. Hospitals
9.2.2. Ambulatory Surgical Centers
9.2.3. Specialty Clinics
9.2.4. Others
9.3. Global Lyophilized Injectable Drugs Market Analysis, by End-user
9.4. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by End-user


10. Global Lyophilized Injectable Drugs Market Analysis, by Region
10.1. Global Lyophilized Injectable Drugs Market Size and Forecast, by Region, 2016–2026
10.1.1. North America
10.1.2. Europe
10.1.3. Asia Pacific
10.1.4. Latin America
10.1.5. Middle East & Africa
10.2. Global Lyophilized Injectable Drugs Market Analysis, by Region
10.3. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Region


11. North America Lyophilized Injectable Drugs Market Analysis
11.1. North America Lyophilized Injectable Drugs Market
11.2. North America Lyophilized Injectable Drugs Market Overview
11.3. North America Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging
11.3.1. Single-use Vials
11.3.2. Point-of-Care Reconstitution
11.3.3. Specialty Packaging
11.3.4. Others
11.4. North America Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
11.4.1. Prefilled Diluent Syringes
11.4.2. Proprietary Reconstitution Devices
11.4.3. Single-step Devices
11.4.4. Multi-step Devices
11.5. North America Lyophilized Injectable Drugs Market Size and Forecast, by Indication
11.5.1. Autoimmune Diseases
11.5.2. Infectious Diseases
11.5.3. Metabolic Conditions
11.5.4. Others
11.6. North America Lyophilized Injectable Drugs Market Size and Forecast, by End-user
11.6.1. Hospitals
11.6.2. Ambulatory Surgical Centers
11.6.3. Specialty Clinics
11.6.4. Others
11.7. North America Lyophilized Injectable Drugs Market Forecast, by Country
11.7.1. U.S.
11.7.2. Canada
11.8. North America Lyophilized Injectable Drugs Market Attractiveness Analysis
11.8.1. By Type of Packaging
11.8.2. By Type of Delivery
11.8.3. By Indication
11.8.4. By End-user
11.8.5. By Country


12. Europe Lyophilized Injectable Drugs Market Analysis
12.1. Europe Lyophilized Injectable Drugs Market
12.2. Europe Lyophilized Injectable Drugs Market Overview
12.3. Europe Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging
12.3.1. Single-use Vials
12.3.2. Point-of-Care Reconstitution
12.3.3. Specialty Packaging
12.3.4. Others
12.4. Europe Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
12.4.1. Prefilled Diluent Syringes
12.4.2. Proprietary Reconstitution Devices
12.4.3. Single-step Devices
12.4.4. Multi-step Devices
12.5. Europe Lyophilized Injectable Drugs Market Size and Forecast, by Indication
12.5.1. Autoimmune Diseases
12.5.2. Infectious Diseases
12.5.3. Metabolic Conditions
12.5.4. Others
12.6. Europe Lyophilized Injectable Drugs Market Size and Forecast, by End-user
12.6.1. Hospitals
12.6.2. Ambulatory Surgical Centers
12.6.3. Specialty Clinics
12.6.4. Others
12.7. Europe Lyophilized Injectable Drugs Market Forecast, by Country/Sub-region
12.7.1. U.K.
12.7.2. France
12.7.3. Germany
12.7.4. Spain
12.7.5. Italy
12.7.6. Rest of Europe
12.8. Europe Lyophilized Injectable Drugs Market Attractiveness Analysis
12.8.1. By Type of Packaging
12.8.2. By Type of Delivery
12.8.3. By Indication
12.8.4. By End-user
12.8.5. By Country/Sub-region

13. Asia Pacific Lyophilized Injectable Drugs Market Analysis
13.1. Asia Pacific Lyophilized Injectable Drugs Market Key Findings
13.2. Asia Pacific Lyophilized Injectable Drugs Market Overview
13.3. Asia Pacific Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging
13.3.1. Single-use Vials
13.3.2. Point-of-Care Reconstitution
13.3.3. Specialty Packaging
13.3.4. Others
13.4. Asia Pacific Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
13.4.1. Prefilled Diluent Syringes
13.4.2. Proprietary Reconstitution Devices
13.4.3. Single-step Devices
13.4.4. Multi-step Devices
13.5. Asia Pacific Lyophilized Injectable Drugs Market Size and Forecast, by Indication
13.5.1. Autoimmune Diseases
13.5.2. Infectious Diseases
13.5.3. Metabolic Conditions
13.5.4. Others
13.6. Asia Pacific Lyophilized Injectable Drugs Market Size and Forecast, by End-user
13.6.1. Hospitals
13.6.2. Ambulatory Surgical Centers
13.6.3. Specialty Clinics
13.6.4. Others
13.7. Asia Pacific Lyophilized Injectable Drugs Market Forecast, by Country/Sub-region
13.7.1. China
13.7.2. India
13.7.3. Japan
13.7.4. Australia & New Zealand
13.7.5. Rest of Asia Pacific
13.8. Asia Pacific Lyophilized Injectable Drugs Market Attractiveness Analysis
13.8.1. By Type of Packaging
13.8.2. By Type of Delivery
13.8.3. By Indication
13.8.4. By End-user
13.8.5. By Country/Sub-region


14. Latin America Lyophilized Injectable Drugs Market Analysis
14.1. Latin America Lyophilized Injectable Drugs Market Key Findings
14.2. Latin America Lyophilized Injectable Drugs Market Overview
14.3. Latin America Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging
14.3.1. Single-use Vials
14.3.2. Point-of-Care Reconstitution
14.3.3. Specialty Packaging
14.3.4. Others
14.4. Latin America Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
14.4.1. Prefilled Diluent Syringes
14.4.2. Proprietary Reconstitution Devices
14.4.3. Single-step Devices
14.4.4. Multi-step Devices
14.5. Latin America Lyophilized Injectable Drugs Market Size and Forecast, by Indication
14.5.1. Autoimmune Diseases
14.5.2. Infectious Diseases
14.5.3. Metabolic Conditions
14.5.4. Others
14.6. Latin America Lyophilized Injectable Drugs Market Size and Forecast, by End-user
14.6.1. Hospitals
14.6.2. Ambulatory Surgical Centers
14.6.3. Specialty Clinics
14.6.4. Others
14.7. Latin America Lyophilized Injectable Drugs Market Forecast, by Country/Sub-region
14.7.1. Brazil
14.7.2. Mexico
14.7.3. Rest of Latin America
14.8. Latin America Lyophilized Injectable Drugs Market Attractiveness Analysis
14.8.1. By Type of Packaging
14.8.2. By Type of Delivery
14.8.3. By Indication
14.8.4. By End-user
14.8.5. By Country/Sub-region


15. Middle East & Africa Lyophilized Injectable Drugs Market Analysis
15.1. Middle East & Africa Lyophilized Injectable Drugs Market
15.2. Middle East & Africa Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging
15.2.1. Single-use Vials
15.2.2. Point-of-Care Reconstitution
15.2.3. Specialty Packaging
15.2.4. Others
15.3. Middle East & Africa Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
15.3.1. Prefilled Diluent Syringes
15.3.2. Proprietary Reconstitution Devices
15.3.3. Single-step Devices
15.3.4. Multi-step Devices
15.4. Middle East & Africa Lyophilized Injectable Drugs Market Size and Forecast, by Indication
15.4.1. Autoimmune Diseases
15.4.2. Infectious Diseases
15.4.3. Metabolic Conditions
15.4.4. Others
15.5. Middle East & Africa Lyophilized Injectable Drugs Market Size and Forecast, by End-user
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Specialty Clinics
15.5.4. Others
15.6. Middle East & Africa Lyophilized Injectable Drugs Market Forecast, by Country/Sub-region
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness Analysis
15.7.1. By Type of Packaging
15.7.2. By Type of Delivery
15.7.3. By Indication
15.7.4. By End-user
15.7.5. By Country/Sub-region


16. Competition Landscape
16.1. Company Profiles
16.1.1. B. Braun Melsungen AG
16.1.1.1. Overview (HQ, Employee Strength, Business Segments)
16.1.1.2. Financials
16.1.1.3. Recent Developments
16.1.1.4. Strategy
16.1.2. Baxter
16.1.2.1. Overview (HQ, Employee Strength, Business Segments)
16.1.2.2. Financials
16.1.2.3. Recent Developments
16.1.2.4. Strategy
16.1.3. Becton, Dickinson and Company
16.1.3.1. Overview (HQ, Employee Strength, Business Segments)
16.1.3.2. Financials
16.1.3.3. Recent Developments
16.1.3.4. Strategy
16.1.4. Mylan N.V.
16.1.4.1. Overview (HQ, Employee Strength, Business Segments)
16.1.4.2. Financials
16.1.4.3. Recent Developments
16.1.4.4. Strategy
16.1.5. Schott AG
16.1.5.1. Overview (HQ, Employee Strength, Business Segments)
16.1.5.2. Financials
16.1.5.3. Recent Developments
16.1.5.4. Strategy
16.1.6. SHL Group
16.1.6.1. Overview (HQ, Employee Strength, Business Segments)
16.1.6.2. Financials
16.1.6.3. Recent Developments
16.1.6.4. Strategy
16.1.7. Vetter Pharma
16.1.7.1. Overview (HQ, Employee Strength, Business Segments)
16.1.7.2. Financials
16.1.7.3. Recent Developments
16.1.7.4. Strategy
16.1.8. CIRON Drugs & Pharmaceuticals Pvt. Ltd.
16.1.8.1. Overview (HQ, Employee Strength, Business Segments)
16.1.8.2. Financials
16.1.8.3. Recent Developments
16.1.8.4. Strategy
16.1.9. Jubilant HollisterStier
16.1.9.1. Overview (HQ, Employee Strength, Business Segments)
16.1.9.2. Financials
16.1.9.3. Recent Developments
16.1.9.4. Strategy



List of Figures



FIG. 1 Global Lyophilized Injectable Drugs Market Size (US$ Mn) Forecast, 2018–2026
FIG. 2 Global Lyophilized Injectable Drugs Market Value Share, by Type of Packaging, 2017
FIG. 3 Global Lyophilized Injectable Drugs Market Value Share, Indication, 2017
FIG. 4 Global Lyophilized Injectable Drugs Market Value Share, by Type of Delivery, 2017
FIG. 5 Global Lyophilized Injectable Drugs Market Value Share, End-user, 2017
FIG. 6 Global Lyophilized Injectable Drugs Market Value Share (%), by Type of Packaging, 2017 and 2026
FIG. 7 Global Lyophilized Injectable Drugs Market Attractiveness, by Type of Packaging, 2018–2026
FIG. 8 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Single-use Vials, 2016–2026
FIG. 9 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Point-of-care Reconstitution, 2016–2026
FIG. 10 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Specialty Packaging, 2016–2026
FIG. 11 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
FIG. 12 Global Lyophilized Injectable Drugs Market Value Share (%), by Type of Delivery, 2017 and 2026
FIG. 13 Global Lyophilized Injectable Drugs Market Attractiveness, by Type of Delivery, 2018–2026
FIG. 14 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Prefilled Diluent Syringes, 2016–2026
FIG. 15 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Proprietary Reconstitution Devices, 2016–2026
FIG. 16 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Single-step Devices, 2016–2026
FIG. 17 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Multi-step Devices, 2016–2026
FIG. 18 Global Lyophilized Injectable Drugs Market Value Share (%), by Indication, 2017 and 2026
FIG. 19 Global Lyophilized Injectable Drugs Market Attractiveness, by Indication, 2018–2026
FIG. 20 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Autoimmune Diseases, 2016–2026
FIG. 21 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Infectious Diseases, 2016–2026
FIG. 22 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Metabolic Conditions, 2016–2026
FIG. 23 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
FIG. 24 Global Lyophilized Injectable Drugs Market Value Share Analysis, by End-user, 2017 and 2026
FIG. 25 Global Lyophilized Injectable Drugs Market Attractiveness, by End-user, 2018–2026
FIG. 26 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2016–2026
FIG. 27 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Ambulatory Surgical Centers, 2016–2026
FIG. 28 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Specialty Clinics, 2016–2026
FIG. 29 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
FIG. 30 Global Lyophilized Injectable Drugs Market Value Share Analysis, by Region, 2016 and 2025
FIG. 31 Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Region, 2018–2026
FIG. 32 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
FIG. 33 North America Lyophilized Injectable Drugs Market Value Share, by Country, 2017 and 2026
FIG. 34 North America Lyophilized Injectable Drugs Market Attractiveness, by Country, 2018–2026
FIG. 35 North America Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Packaging, 2017 and 2026
FIG. 36 North America Lyophilized Injectable Drugs Market Attractiveness, by Type of Packaging, 2018–2026
FIG. 37 North America Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Delivery, 2017 and 2026
FIG. 38 North America Lyophilized Injectable Drugs Market Attractiveness, by Type of Delivery, 2018–2026
FIG. 39 North America Lyophilized Injectable Drugs Market Value Share Analysis, by Indication, 2017 and 2026
FIG. 40 North America Lyophilized Injectable Drugs Market Attractiveness, by Indication, 2018–2026
FIG. 41 North America Lyophilized Injectable Drugs Market Value Share Analysis, by End-user, 2017 and 2026
FIG. 42 North America Lyophilized Injectable Drugs Market Attractiveness, by End-user, 2018–2026
FIG. 43 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
FIG. 44 Europe Lyophilized Injectable Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
FIG. 45 Europe Lyophilized Injectable Drugs Market Attractiveness, by Country/Sub-region, 2018–2026
FIG. 46 Europe Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Packaging, 2017 and 2026
FIG. 47 Europe Lyophilized Injectable Drugs Market Attractiveness, by Type of Packaging, 2018–2026
FIG. 48 Europe Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Delivery, 2017 and 2026
FIG. 49 Europe Lyophilized Injectable Drugs Market Attractiveness, by Type of Delivery, 2018–2026
FIG. 50 Europe Lyophilized Injectable Drugs Market Value Share Analysis, by Indication, 2017 and 2026
FIG. 51 Europe Lyophilized Injectable Drugs Market Attractiveness, by Indication, 2018–2026
FIG. 52 Europe Lyophilized Injectable Drugs Market Value Share Analysis, by End-user, 2017 and 2026
FIG. 53 Europe Lyophilized Injectable Drugs Market Attractiveness, by End-user, 2018–2026
FIG. 54 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
FIG. 55 Asia Pacific Lyophilized Injectable Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
FIG. 56 Asia Pacific Lyophilized Injectable Drugs Market Attractiveness, by Country/Sub-region, 2018–2026
FIG. 57 Asia Pacific Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Packaging, 2017 and 2026
FIG. 58 Asia Pacific Lyophilized Injectable Drugs Market Attractiveness, by Type of Packaging, 2018–2026
FIG. 59 Asia Pacific Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Delivery, 2017 and 2026
FIG. 60 Asia Pacific Lyophilized Injectable Drugs Market Attractiveness, by Type of Delivery, 2018–2026
FIG. 61 Asia Pacific Lyophilized Injectable Drugs Market Value Share Analysis, by Indication, 2017 and 2026
FIG. 62 Asia Pacific Lyophilized Injectable Drugs Market Attractiveness, by Indication, 2018–2026
FIG. 63 Asia Pacific Lyophilized Injectable Drugs Market Value Share Analysis, by End-user, 2017 and 2026
FIG. 64 Asia Pacific Lyophilized Injectable Drugs Market Attractiveness, by End-user, 2018–2026
FIG. 65 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
FIG. 66 Latin America Lyophilized Injectable Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
FIG. 67 Latin America Lyophilized Injectable Drugs Market Attractiveness, by Country/Sub-region, 2018–2026
FIG. 68 Latin America Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Packaging, 2017 and 2026
FIG. 69 Latin America Lyophilized Injectable Drugs Market Attractiveness, by Type of Packaging, 2018–2026
FIG. 70 Latin America Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Delivery, 2017 and 2026
FIG. 71 Latin America Lyophilized Injectable Drugs Market Attractiveness, by Type of Delivery, 2018–2026
FIG. 72 Latin America Lyophilized Injectable Drugs Market Value Share Analysis, by Indication, 2017 and 2026
FIG. 73 Latin America Lyophilized Injectable Drugs Market Attractiveness, by Indication, 2018–2026
FIG. 74 Latin America Lyophilized Injectable Drugs Market Value Share Analysis, by End-user, 2017 and 2026
FIG. 75 Latin America Lyophilized Injectable Drugs Market Attractiveness, by End-user, 2018–2026
FIG. 76 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
FIG. 77 Middle East & Africa Lyophilized Injectable Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
FIG. 78 Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness, by Country/Sub-region, 2018–2026
FIG. 79 Middle East & Africa Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Packaging, 2017 and 2026
FIG. 80 Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness, by Type of Packaging, 2018–2026
FIG. 81 Middle East & Africa Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Delivery, 2017 and 2026
FIG. 82 Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness, by Type of Delivery, 2018–2026
FIG. 83 Middle East & Africa Lyophilized Injectable Drugs Market Value Share Analysis, by Indication, 2017 and 2026
FIG. 84 Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness, by Indication, 2018–2026
FIG. 85 Middle East & Africa Lyophilized Injectable Drugs Market Value Share Analysis, by End-user, 2017 and 2026
FIG. 86 Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness, by End-user, 2018–2026

 

List of Tables



TABLE 1 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 2 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 3 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 4 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 5 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Region, 2016–2026
TABLE 6 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country, 2016–2026
TABLE 7 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 8 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 9 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 10 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 11 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 12 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 13 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 14 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 15 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 16 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 17 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 18 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 19 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 20 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 21 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 22 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 23 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 24 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 25 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 26 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 27 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 28 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 29 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 30 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026